Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.
April Roach is a breaking news reporter with a focus on multinational news, particularly in the Netherlands. She has written for various publications including Bloomberg News, Evening Standard, and Fortune, covering a wide range of topics including politics, business, and culture. Her work has also appeared in Bloomberg Law, Business Day, Yahoo Finance, and other prominent publications.